Company
Zoetic International plc
Headquarters: London, United Kingdom
Employees: 13
Zoetic International plc Categories
United Kingdom Healthcare Drug Manufacturers—Specialty & GenericUnited Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Zoetic International Plc, a vertically integrated CBD company, researches, develops, produces, and sells cannabidiol (CBD) consumer products and other hemp derivatives in the United States and the United Kingdom. The company offers oral CBD tinctures and CBD gummies, as well as softgel, massage oil, and skincare products. Its CBD products are used for pharmaceutical and tobacco replacement applications. The company was formerly known as Highlands Natural Resources plc and changed its name to Zoetic International Plc in September 2019. Zoetic International Plc was founded in 2014 and is headquartered in London, the United Kingdom.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Zoetic International plc has the following listings and related stock indices.
Stock: LSE: ZOE wb_incandescent